Featured Grant OpportunityTeen Pregnancy Prevention (TPP) Program (Funding Opportunities)
Featured Grant OpportunitySchool Emergency Response to Violence (Project SERV) (Funding Opportunity)
Featured Grant OpportunityStreet Outreach Program (Funding Opportunities)
Featured Grant OpportunityChild Victims and Witnesses Support Materials: Outreach and Implementation Project (Funding…
Featured Grant OpportunityCharter School Programs (CSP) (Funding Opportunity)
Featured Grant OpportunityTribal Victim Services Set-Aside Formula Program (Funding Opportunity)
Featured Grant OpportunitySafe Streets and Roads for All (SS4A) (Funding Opportunity)
Featured Grant OpportunityAddressing the Needs of Incarcerated Parents and Their Minor Children (Funding Opportunity)
Featured Grant OpportunityMultistate Mentoring Programs Initiative (Funding Opportunity)
Featured Grant OpportunityNational Communication System (NCS) for Runaway and Homeless Youth Program Notice of Funding…
Featured Grant OpportunityDisability Innovation Fund - Pathways to Partnerships (Funding Opportunity)
Featured Grant OpportunityResearch on Juvenile Justice Topics (Funding Opportunity)
Featured Grant OpportunityChildren and Youth Resilience Challenge (Funding Opportunity)
Featured Grant OpportunityFY 2023 Youth Violence Prevention Program (Funding Opportunity)
Novavax Approved by CDC as an Additional COVID-19 Vaccine for Adolescents
The CDC recently approved Novavax’s COVID-19 vaccine to be used as another primary series option for adolescents ages 12 through 17. This recommendation follows the FDA’s emergency use authorization for the vaccine for this age group.
Novavax uses protein subunit technology, the same technology used in the Influenza and Whooping Cough vaccines, to help the immune system respond to the virus in the future. Learn more.